LBLTF

Lattice Biologics Ltd

 
Ordinary Shares International Reporting
OTCQB
Verified Company Profile 5/24/2017
Contact Info
  • 16701 N 90th Street
  • Suite 101
  • Scottsdale, AZ 85260

Business Description


 
Financial Reporting/Disclosure
Reporting Status International Reporting: TSX Venture Exchange
Audited Financials Audited
Latest Report Jun 30, 2017 Interim Financial Report
CIK 0001031020
Fiscal Year End 9/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: British Columbia, Canada
Year of Inc. 1989
Employees Not Available
Company Officers/Contacts
Guy S. Cook CEO
Cheryl A. Farmer CFO
Company Directors
Guy S. Cook
Cheryl A. Farmer
Donald A. McInnes
Mario Stifano
Cathy Thomas
Company Notes
  • Formerly=Blackstone Ventures Inc. until 1-2016
Service Providers
Accounting/Auditing Firm
Meyers Norris Penny, LLP
900- 50 Burnhamthorpe Road West
Sussex Centre
Mississauga, ONT, L5B3C2
Canada

Legal Counsel
Clarence Mulligan
2820 S Alma School Road
#18
PO Box 155
Chandler, AZ, 85248
United States

Investor Relations Firm
Not Available
LBLTF Security Details
Share Structure
Market Value1 $5,947,806 a/o Sep 20, 2017
Authorized Shares Unlimited a/o Dec 12, 2016
Outstanding Shares 71,833,409 a/o Dec 12, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 67,178,119 a/o Dec 13, 2016
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
CST Trust Company
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
LBL - TSX Venture Exchange - Qualified
Short Selling Data
Short Interest 85,300 (100%)
Aug 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security